368 related articles for article (PubMed ID: 23108408)
21. A role for matrix remodelling proteins in invasive and malignant meningiomas.
Jalali S; Singh S; Agnihotri S; Wataya T; Salehi F; Alkins R; Burrell K; Navab R; Croul S; Aldape K; Zadeh G
Neuropathol Appl Neurobiol; 2015 Feb; 41(2):e16-28. PubMed ID: 24989599
[TBL] [Abstract][Full Text] [Related]
22. NDRG4, the N-Myc downstream regulated gene, is important for cell survival, tumor invasion and angiogenesis in meningiomas.
Kotipatruni RP; Ferraro DJ; Ren X; Vanderwaal RP; Thotala DK; Hallahan DE; Jaboin JJ
Integr Biol (Camb); 2012 Oct; 4(10):1185-97. PubMed ID: 22869042
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-224 targets ERG2 and contributes to malignant progressions of meningioma.
Wang M; Deng X; Ying Q; Jin T; Li M; Liang C
Biochem Biophys Res Commun; 2015 May; 460(2):354-61. PubMed ID: 25783051
[TBL] [Abstract][Full Text] [Related]
24. The expression of fatty acid metabolism-associated proteins is correlated with the prognosis of meningiomas.
Jiang J; Lin C; Liu N; Zhang Z; Sun Y; Fang X; Qi J
APMIS; 2013 Oct; 121(10):997-1003. PubMed ID: 23879478
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of extracellular matrix-related genes in rare variants of meningioma.
Kwon MJ; Sung CO; Kang SY; Do IG; Suh YL
Hum Pathol; 2013 Feb; 44(2):260-8. PubMed ID: 22995327
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas.
Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K
Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227
[TBL] [Abstract][Full Text] [Related]
27. A comparison of the cell lines used in meningioma research.
Ragel BT; Couldwell WT; Gillespie DL; Wendland MM; Whang K; Jensen RL
Surg Neurol; 2008 Sep; 70(3):295-307; discussion 307. PubMed ID: 18261772
[TBL] [Abstract][Full Text] [Related]
28. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
[TBL] [Abstract][Full Text] [Related]
29. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.
Lusis EA; Watson MA; Chicoine MR; Lyman M; Roerig P; Reifenberger G; Gutmann DH; Perry A
Cancer Res; 2005 Aug; 65(16):7121-6. PubMed ID: 16103061
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
[TBL] [Abstract][Full Text] [Related]
31. An allele of rs619586 polymorphism in MALAT1 alters the invasiveness of meningioma via modulating the expression of collagen type V alpha (COL5A1).
Zheng J; Pang CH; Du W; Wang L; Sun LG; Xing ZY
J Cell Mol Med; 2020 Sep; 24(17):10223-10232. PubMed ID: 32720739
[TBL] [Abstract][Full Text] [Related]
32. Selective expression of CD44 messenger RNA splice variants in four high grade human brain tumour cell lines.
Harn HJ; Lee HS; Ho LI; Lee WH; Ding JH
Biochem Mol Biol Int; 1994 Jul; 33(4):743-9. PubMed ID: 7526922
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical study of MRP5 expression in meningiomas.
Alexiou GA; Goussia A; Ntoulia A; Zagorianakou P; Malamou-Mitsi V; Voulgaris S; Kyritsis AP
Cancer Chemother Pharmacol; 2013 Mar; 71(3):825-8. PubMed ID: 23271324
[TBL] [Abstract][Full Text] [Related]
34. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway.
Schrell UM; Rittig MG; Anders M; Kiesewetter F; Marschalek R; Koch UH; Fahlbusch R
J Neurosurg; 1997 May; 86(5):845-52. PubMed ID: 9126901
[TBL] [Abstract][Full Text] [Related]
35. Benign and atypical meningioma metabolic signatures by high-resolution magic-angle spinning molecular profiling.
Monleón D; Morales JM; Gonzalez-Darder J; Talamantes F; Cortés O; Gil-Benso R; López-Ginés C; Cerdá-Nicolás M; Celda B
J Proteome Res; 2008 Jul; 7(7):2882-8. PubMed ID: 18507434
[TBL] [Abstract][Full Text] [Related]
36. Expression of matrix metalloproteinases, their inhibitors, and urokinase plasminogen activator in human meningiomas.
Siddique K; Yanamandra N; Gujrati M; Dinh D; Rao JS; Olivero W
Int J Oncol; 2003 Feb; 22(2):289-94. PubMed ID: 12527924
[TBL] [Abstract][Full Text] [Related]
37. Anaplastic and atypical meningiomas express high levels of Fas and undergo apoptosis in response to Fas ligation.
Weisberg S; Ashkenazi E; Israel Z; Attia M; Shoshan Y; Umansky F; Brodie C
Am J Pathol; 2001 Oct; 159(4):1193-7. PubMed ID: 11583945
[TBL] [Abstract][Full Text] [Related]
38. [Expression of integrin-alpha 3 mRNA in meningiomas and its biological significance].
Chen J; Xu XP
Ai Zheng; 2002 May; 21(5):526-9. PubMed ID: 12452046
[TBL] [Abstract][Full Text] [Related]
39. MiR-34a-3p alters proliferation and apoptosis of meningioma cells
Werner TV; Hart M; Nickels R; Kim YJ; Menger MD; Bohle RM; Keller A; Ludwig N; Meese E
Aging (Albany NY); 2017 Mar; 9(3):932-954. PubMed ID: 28340489
[TBL] [Abstract][Full Text] [Related]
40. Metabolic aggressiveness in benign meningiomas with chromosomal instabilities.
Monleón D; Morales JM; Gonzalez-Segura A; Gonzalez-Darder JM; Gil-Benso R; Cerdá-Nicolás M; López-Ginés C
Cancer Res; 2010 Nov; 70(21):8426-34. PubMed ID: 20861191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
